Monkeypox Disease Diagnostics Market Size, Share, By Testing Method (Real-Time/Conventional PCR, Sequencing, Serological Tests, Viral Culture, Immunohistochemistry, and Others), Sample Type (Skin Lesion Swabs, Exudates, Roofs, and Crusts), End-Use (Hospitals & Clinics, Diagnostic Laboratories, and Others), and Region - Trends, Analysis, and Forecast till 2035

Report Code: PMI489522 | Publish Date: May 2024 | No. of Pages: 170

Monkeypox Disease Diagnostics Market Companies

  • Labcorp
  • ARUP Laboratories
  • Mirimus
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • JOYSBIO (Tianjin) Biotechnology Co., Ltd
  • BIOMÉRIEUX
  • Quest Diagnostics Incorporated
  • Sonic Reference Laboratory
  • BioGX
  • Bio-Rad Laboratories, Inc.
  • Cepheid
  • Sonic Reference Laboratory

 

Recent News:

  • bioMérieux launched a PCR kit called the MONKEYPOX R-GENE to allow qualitative detection of virus, in October 2024. The MONKEYPOX R-GENE test can be carried out by any type of laboratory using nucleic acid extraction and amplification platforms commonly available on the market. A result is obtained in four to five hours. The test design aimed to enable reliable detection through the detection of two different genes, even in the event of possible monkeypox mutations.
  • Bluestain Global, a British Portuguese joint-venture, announced the launch of the Bluestain MPox virus detection kit, in August 2024. The new rapid detection test for the monkeypox virus was engineered with cutting-edge molecular techniques, delivering unmatched speed and accuracy at a critical moment.  The test offered unparalleled sensitivity and specificity and delivered results within 15 to 30 minutes.

Monkeypox Disease Diagnostics Market Companies Forecast 2025-2035